Lupus pancreatitis complicated with pseudocyst in a teenage girl, a case report
Keywords:
Lupus Erythematosus Systemyc, Acute Necrotizing, Abdominal PainAbstract
Introduction: systemic lupus erythematosus (LES) is a chronic inflammatory disease of autoimmune nature and unknown etiology, characterized by multiple organ and system involvement and by the presence of antinuclear antibodies. It can appear at any age, with a peak incidence at 12 years of age. The clinical picture of the disease is variable, both in the initial phase and in the course of its evolution. Lupus pancreatitis is one of the rarest manifestations of the disease, its etiopathogenesis is unknown and it is related to vasculitic phenomena, immunocomplex deposition and thromboembolic phenomena.
Objective: to describe the clinical, humoral and imaging evolution of an adolescent girl who presented lupus pancreatitis complicated by the formation of pancreatic pseudocyst.
Case Report: a 17-year-old female adolescent with a personal history of Systemic Lupus Erythematosus Erythematosus since 2021. She was attended at the emergency services of the Pediatric Hospital "Juan Manuel M?rquez", due to abdominal pain in upper hemiabdomen associated with incoercible vomiting and bilious character. She was diagnosed with lupus pancreatitis complicated with pseudocyst.
Conclusions: acute pancreatitis in teenage with Systemic Lupus Erythematosus Erythematosus is a rare complication. Therapeutic actions should be implemented as soon as possible. Although SLE-induced pancreatic involvement is characterized by increased mortality as well as increased disease activity, timely diagnosis of the patient allowed a good outcome. Stomatological surgical risk in patients from office three of the South Area of G?ines, Mayabeque, Cuba
Downloads
References
Mussano E, Onetti L, Cadile I, Werner M, Ruffin A, Buliubasich S, et al. Lupus eritematoso sistémico: datos sociodemográficos y su correlación clínicoanalítica en un hospital universitario. Rev. argent. reumatolg. 2019 [citado 29 de julio de 2022]; 30(3): 5-12. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S236236752019000400002&lng=es.
Coronado AK, Sánchez A, Stichweh D, McCarthy F, Espino M. Manifestaciones gastrointestinales en el Lupus Eritematoso Sistémico: un espectro diferente. Pediátr Panamá. 2019 [citado 29 de julio de 2022]; 48(1): 30-34. Disponible en: https://docs.bvsalud. org/biblioref/2019/06/1000427/pag-13.pdf
Morales Díaz A, Pérez Montes de Oca E, Belaunde Clausell A. Taponamiento cardiaco como presentación del Lupus Eritematoso Sistémico. Rev. Cub. Med. 2022 [citado 29 de julio de 2022]; 61(4): [aprox. 12 p.]. Disponible en: https://revmedicina.sld.cu/ index.php/med/article/view/2801
Blanco Ornelas LH, Martín Nares E, Aguirre Muñoz MA, López Iñiguez A, Valerdi Contreras L. Pancreatitis aguda como presentación inicial de lupus eritematoso sistémico. Revista Médica. 2016 [citado 29 de julio de 2022]; 7(3):196-199. Disponible en: https:// www.medigraphic.com/cgi-bin/new/resumen. cgi?IDARTICULO=65578
Barría Romero R. Systemic Lupus Erythematosus, a multidisciplinary disease. Andes pediatr. 2021 [citado 29 de julio de 2022]; 92(3): 337-338. Disponible en: http://www.scielo.cl/scielo.php?script=sci_ arttext&pid=S2452-60532021000300337&lng=es.
Domínguez Pinilla N, Enríquez E, Medina E, Rasero M, Inocencio J. Pancreatitis y Lupus. Anales de Pediatría. 2012 [citado 29/07/2022]; 77(2):142-143. Disponible en: https://www.analesdepediatria.org/ es-pancreatitis-lupus-articulo-S169540331200152X
Palomino Cabrera A, Cruz González M, Mesa izquierdo O. Caracterización clínica y epidemiológica de pacientes con pancreatitis aguda en un servicio de Cirugía General. Progaleno. 2021 [citado 29 de julio de 2022]; 4(3) [aprox. 9p.]. Disponible en: https:// revprogaleno.sld.cu/index.ph./progaleno/article/ view/306
Palacios Idrovo JP, Freire Palacios MA, Paguay Moreno ÁR, Echeverria Oviedo CM. Pancreatic pseudocyst as a complication of a patient with systemic lupus erythematosus. Rev Cuba Reumatol [Internet]. 2019 [citado 29 de julio de 2022]; 21(Suppl 1): e65. Disponible en: http://scielo. sld.cu/scielo.php?script=sci_arttext&pid=S181759962019000400007&lng=es.
Lariño Noia J, Macías García F, Seijo Ríos S, Iglesias García J, Domínguez Muñoz J. E. Pancreatitis 04
Pancreatitis lúpica complicada con pseudoquistes en una adolescente. Informe de caso. y lupus eritematoso sistémico. Rev. esp. enferm. dig. 2009 [citado 29 de julio de 2022]; 101(8): 571-579. Disponible en: http://scielo.isciii. es/scielo.php?script=sci_arttext&pid=S113001082009000800009&lng=es.
Yu feng Li, Min jiang Wei. Pancreatitis aguda en el lupus eritematoso sistémico de inicio en la niñez: A propósito de un caso. Arch. argent. pediatr. 2019 citado 29 de julio de 2022]; 117(3): e279-e283. Disponible en: http://www.scielo. org.ar/scielo.php?script=sci_arttext&pid=S032500752019000300024&lng=es.
Praveen Pratap J, Saourabh Rajesh D, J Janhavee Praveen J, Lata Sunil B. Acute pancreatitis in rheumatology practice, with emphasis on systemic lupus erythematosus: A case series and newer concepts. Indian Journal of Rheumatology. 2019 [citado 29 de julio de 2022];14(3): 229235. Disponible en: https://journals.lww.com/ ijru/fulltext/2019/14030/acute_pancreatitis_in_ rheumatology_practice,_with.13.aspx
Sheba C, Benzeeta P, Vineeta S. Pancreatitis in systemic lupus erythematosus: Clinical characterization and outcome analysis in concurrent pancreatitis and lupus. Indian Journal of Rheumatology. 2021 [citado 29 de julio de 2022]; 16(2): 209-213. Disponible en: https://journals. lww.com/ijru/fulltext/2021/16020/pancreatitis_ in_systemic_lupus_erythematosus_.15.aspx
Saab S, Corr MP, Weissman Mh. Corticosteroids and systemic lupus erythematosus pancreatitis: a case series. J Rheumatol. 1998 [citado 29 de julio de 2022]; 25(4): 801-6. Disponible en: https://pubmed. ncbi.nlm.nih.gov/9558190/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Yanet Romero Reinaldo, Santa Yarelis Gómez Conde
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free of:
- Share copy and redistribute the material in any medium or format
- Adapt Remix, transform and build from material
- The licensor cannot revoke these freedoms as long as you follow the terms of the license
Under the following terms:
- Attribution - Oh, it's a good thing. You must give adequate credit , provide a link to the license, e indicate whether changes have been made . You can do it in any reasonable way, but not in such a way as to suggest that you or your use have the support of the licensor.
- Non-Commercial - Oh, it's a . You can't make use of the material with commercial purposes .
- No additional restrictions You can't apply legal terms or technological measures that legally restrict others from making any use permitted by the license.